Publications by authors named "April A N Rose"

19Publications

BRAF Mutation Class and Clinical Outcomes-Letter.

Clin Cancer Res 2019 05;25(10):3188

Faculty of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
May 2019

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Oncogene 2018 06 15;37(24):3183-3199. Epub 2018 Mar 15.

Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada.

View Article and Find Full Text PDF
June 2018

Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer.

Pharmacol Ther 2017 Nov 22;179:127-141. Epub 2017 May 22.

Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada; Department of Biochemistry, McGill University, Montréal, Québec, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada; Department of Oncology, McGill University, Montréal, Québec, Canada. Electronic address:

View Article and Find Full Text PDF
November 2017

Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.

Breast Cancer Res 2015 Mar 27;17:45. Epub 2015 Mar 27.

Goodman Cancer Research Centre, McGill University, 1160 Pine Avenue West, Room 513, Montréal, QC, H3A 1A3, Canada.

View Article and Find Full Text PDF
March 2015

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.

J Clin Oncol 2014 Nov 29;32(32):3619-25. Epub 2014 Sep 29.

Johanna Bendell and Suzanne Jones, Sarah Cannon Research Institute, Nashville, TN; Mansoor Saleh, Georgia Cancer Specialists, Atlanta, GA; April A.N. Rose and Peter M. Siegel, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada; Lowell Hart, Florida Cancer Specialists, Fort Myers; Surendra Sirpal, Hematology Oncology Associates, Lake Worth, FL; Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, and Thomas Davis, Celldex Therapeutics; and Linda Vahdat, Weill Cornell Medical College, New York, NY.

View Article and Find Full Text PDF
November 2014

Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis.

Breast Cancer Res Treat 2013 Oct 9;141(3):331-9. Epub 2013 Oct 9.

Faculty of Medicine, McGill University, McIntyre Medical Building, 3655 Sir William Osler, Montreal, QC, H3G 1Y6, Canada.

View Article and Find Full Text PDF
October 2013

ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.

PLoS One 2010 Aug 10;5(8):e12093. Epub 2010 Aug 10.

Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.

View Article and Find Full Text PDF
August 2010

Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.

Am J Pathol 2010 Jun 9;176(6):3023-31. Epub 2010 Apr 9.

Institut national de la recherche scientifique-Institut Armand-Frappier, Laval, Québec, Canada, H7V 1B7.

View Article and Find Full Text PDF
June 2010

Emerging therapeutic targets in breast cancer bone metastasis.

Future Oncol 2010 Jan;6(1):55-74

Department of Medicine, Goodman Cancer Centre, McGill University, QC H3A 1A3, Canada.

View Article and Find Full Text PDF
January 2010

Osteoactivin promotes breast cancer metastasis to bone.

Mol Cancer Res 2007 Oct;5(10):1001-14

Department of Medicine, McGill University, Montreal, Quebec, Canada.

View Article and Find Full Text PDF
October 2007

Breast cancer-derived factors facilitate osteolytic bone metastasis.

Bull Cancer 2006 Sep;93(9):931-43

Department of Medicine, McGill University, 740 Dr. Penfield Avenue, Room 2201, Montreal, Quebec, Canada, H3A 1A4.

View Article and Find Full Text PDF
September 2006